Myrianthopoulos V - Search Results

1

Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.

Gaboriaud-Kolar N, Myrianthopoulos V, Vougogiannopoulou K, Gerolymatos P, Horne DA, Jove R, Mikros E, Nam S, Skaltsounis AL. Gaboriaud-Kolar N, et al. Among authors: myrianthopoulos v. J Nat Prod. 2016 Oct 28;79(10):2464-2471. doi: 10.1021/acs.jnatprod.6b00285. Epub 2016 Oct 11. J Nat Prod. 2016. PMID: 27726390 Free PMC article.

2

Sesquiterpene lactones from Staehelina fruticosa.

Kotsos MP, Aligiannis N, Myrianthopoulos V, Mitaku S, Skaltsounis L. Kotsos MP, et al. Among authors: myrianthopoulos v. J Nat Prod. 2008 May;71(5):847-51. doi: 10.1021/np070252e. Epub 2008 Apr 5. J Nat Prod. 2008. PMID: 18393461

3

Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF).

Giannakou M, Akrani I, Tsoka A, Myrianthopoulos V, Mikros E, Vorgias C, Hatzinikolaou DG. Giannakou M, et al. Among authors: myrianthopoulos v. Pharmaceuticals (Basel). 2024 Sep 27;17(10):1286. doi: 10.3390/ph17101286. Pharmaceuticals (Basel). 2024. PMID: 39458929 Free PMC article.

4

Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights.

Giannakopoulou E, Akrani I, Mpekoulis G, Frakolaki E, Dimitriou M, Myrianthopoulos V, Vassilaki N, Zoidis G. Giannakopoulou E, et al. Among authors: myrianthopoulos v. Viruses. 2024 Aug 1;16(8):1238. doi: 10.3390/v16081238. Viruses. 2024. PMID: 39205212 Free PMC article.

5

Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy.

Angelopoulou A, Theocharous G, Valakos D, Polyzou A, Magkouta S, Myrianthopoulos V, Havaki S, Fiorillo M, Tremi I, Vachlas K, Nisotakis T, Thanos DF, Pantazaki A, Kletsas D, Bartek J, Petty R, Thanos D, McCrimmon RJ, Papaspyropoulos A, Gorgoulis VG. Angelopoulou A, et al. Among authors: myrianthopoulos v. Mol Cancer. 2024 Jul 25;23(1):147. doi: 10.1186/s12943-024-02061-4. Mol Cancer. 2024. PMID: 39048991 Free PMC article.

6

Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action.

Zuhra K, Petrosino M, Gupta B, Panagaki T, Cecconi M, Myrianthopoulos V, Schneiter R, Mikros E, Majtan T, Szabo C. Zuhra K, et al. Among authors: myrianthopoulos v. Nitric Oxide. 2022 Nov 1;128:12-24. doi: 10.1016/j.niox.2022.07.007. Epub 2022 Aug 13. Nitric Oxide. 2022. PMID: 35973674 Free article.

7

Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.

Spyropoulou Z, Papaspyropoulos A, Lagopati N, Myrianthopoulos V, Georgakilas AG, Fousteri M, Kotsinas A, Gorgoulis VG. Spyropoulou Z, et al. Among authors: myrianthopoulos v. Cells. 2021 Apr 10;10(4):866. doi: 10.3390/cells10040866. Cells. 2021. PMID: 33920220 Free PMC article. Review.

8

Novel Aryl-Substituted Pyrimidones as Inhibitors of 3-Mercaptopyruvate Sulfurtransferase with Antiproliferative Efficacy in Colon Cancer.

Bantzi M, Augsburger F, Loup J, Berset Y, Vasilakaki S, Myrianthopoulos V, Mikros E, Szabo C, Bochet CG. Bantzi M, et al. Among authors: myrianthopoulos v. J Med Chem. 2021 May 13;64(9):6221-6240. doi: 10.1021/acs.jmedchem.1c00260. Epub 2021 Apr 15. J Med Chem. 2021. PMID: 33856792

9

Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors.

Fantel AM, Myrianthopoulos V, Georgoulis A, Lougiakis N, Zantza I, Lamprinidis G, Augsburger F, Marakos P, Vorgias CE, Szabo C, Pouli N, Papapetropoulos A, Mikros E. Fantel AM, et al. Among authors: myrianthopoulos v. Molecules. 2020 Aug 16;25(16):3739. doi: 10.3390/molecules25163739. Molecules. 2020. PMID: 32824311 Free PMC article.

10

Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study.

Pardali V, Giannakopoulou E, Balourdas DI, Myrianthopoulos V, Taylor MC, Šekutor M, Mlinarić-Majerski K, Kelly JM, Zoidis G. Pardali V, et al. Among authors: myrianthopoulos v. Curr Pharm Des. 2020;26(8):838-866. doi: 10.2174/1381612826666200210150127. Curr Pharm Des. 2020. PMID: 32039675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters